title: A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib.
authors.forename: Michele
authors.initials: M
authors.lastname: Cea
authors.forename: Gabriella
authors.initials: G
authors.lastname: Cirmena
authors.forename: Anna
authors.initials: A
authors.lastname: Garuti
authors.forename: Ilaria
authors.initials: I
authors.lastname: Rocco
authors.forename: Claudia
authors.initials: C
authors.lastname: Palermo
authors.forename: Antonia
authors.initials: A
authors.lastname: Cagnetta
authors.forename: Eva
authors.initials: E
authors.lastname: Moran
authors.forename: Nicoletta
authors.initials: N
authors.lastname: Colombo
authors.forename: Raffaella
authors.initials: R
authors.lastname: Grasso
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Fugazza
authors.forename: Marco
authors.initials: M
authors.lastname: Gobbi
authors.forename: Alessio
authors.initials: A
authors.lastname: Nencioni
authors.forename: Alberto
authors.initials: A
authors.lastname: Ballestrero
authors.forename: Franco
authors.initials: F
authors.lastname: Patrone
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000069439:Dasatinib; D005260:Female; D016313:Genes, abl; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics; D009154:Mutation; D011743:Pyrimidines / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib